Arcturus Therapeutics has built a multicultural team, based in San Diego, CA, USA
We have an exciting COVID-19 vaccine candidate that we hope will make a positive difference in the pandemic
See our team describe what it means for them to help get a vaccine to protect people around the world-no matter where you are from
A
S
L
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/JoePayne_LanguageProficiency_V3_1.mp4?time=1664141151
arabic
(عربى)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/MaherA_LanguageProficiency_V3_1.mp4?time=1664141151
chinese
(中文)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_BelleBao.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/BelleBao_LanguageProficiency__V3_1.mp4?time=1664141151
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_HowardYu.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/HowardYu_LanguageProficiency_V3_1.mp4?time=1664141151
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_YurongGuo.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/YurongGuo_LanguageProficiency_V3_1.mp4?time=1664141151
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_XuefengGuo.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/XuefengGuo_LanguageProficiency_V3_1.mp4?time=1664141151
english
(British)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/MikeHodges_LanguageProficiency_V3_1.mp4?time=1664141151
farsi
(فارسی)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2021/01/NedaSafarzadeh_LanguageProficiency_V4.mp4?time=1664141151
french
(Français)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/NadjaEl-mecharrafie_LanguageProficiency_V3_1.mp4?time=1664141151
german
(deutsch)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/LisaKieweg-Thompson_LanguageProficiency_V3_1.mp4?time=1664141151
hebrew
(עִברִית)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_NoaScott.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/NoaScott_LanguageProficiency_V3_1.mp4?time=1664141151
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_TamarGrossman.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/TamarGrossman_LanguageProficiency_V3_1.mp4?time=1664141151
hindi
(हिन्दी)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/PriyaKarmali_LanguageProficiency_V3_1.mp4?time=1664141151
italian
(italiano)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_CristianoSacchetti.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/CristianoSacchetti_LanguageProficiency_V3_1.mp4?time=1664141151
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/thumbnail_GiulioCattarossi.jpg?time=1664141151,https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/GiulioCattarossi_LanguageProficiency_V3_1.mp4?time=1664141151
Japanese
(日本語)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/09/Kiyoshi_Tachikawa_v2.mp4?time=1664141151
korean
(한국어)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/JaeHeonKim_LanguageProficiency_V3_1.mp4?time=1664141151
portuguese
(Português)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/RamonDiazTrelles_LanguageProficiency_V3_1.mp4?time=1664141151
spanish
(español)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/CarlosPerezGarcia_LanguageProficiency__V3_1.mp4?time=1664141151
vietnamese
(Tiếng Việt)
https://secureservercdn.net/104.238.69.59/e32.83a.myftpupload.com/wp-content/uploads/2020/07/HannahHuynh_LanguageProficiency_V3_1.mp4?time=1664141151

Our Team

Grishma Acharya, Senior Manager, In Vivo Pharmacology
Grishma Acharya, Senior Manager, In Vivo Pharmacology
Jocelyn Agliam, Administrative Assistant
Jocelyn Agliam, Administrative Assistant
Maher Alayyoubi, Principal Scientist, Drug Substance
Maher Alayyoubi, Principal Scientist, Drug Substance
Ray Ahn , Senior Manager, Analytical Development
Ray Ahn , Senior Manager, Analytical Development
Claudia Averbuj , Associate Director, Chemistry
Claudia Averbuj , Associate Director, Chemistry
James Barlow, Director of the Board
James Barlow, Director of the BoardBio
Dina Berdieva, Vice President, Clinical Operations
Dina Berdieva, Vice President, Clinical OperationsBio
Stefen Boehme , Director, Head of Drug Discovery
Stefen Boehme , Director, Head of Drug Discovery
Natasha Bowman, Senior Vice President, Head of Human Resources
Natasha Bowman, Senior Vice President, Head of Human ResourcesBio
Juthamart Brady, Research Associate, Drug Discovery
Juthamart Brady, Research Associate, Drug Discovery
Gabbi Caporusso , Clinical Development Associate
Gabbi Caporusso , Clinical Development Associate
Lena Ceballos, Manager, Corporate Communications & Marketing
Lena Ceballos, Manager, Corporate Communications & Marketing
Pad Chivukula, CSO, COO
Pad Chivukula, CSO, COOBio
Connie Cho , Executive Director, Quality Control Operations
Connie Cho , Executive Director, Quality Control Operations
Jenny (Park) Choi , Associate Director, RNA Process Development
Jenny (Park) Choi , Associate Director, RNA Process Development
Maria Chumpitaz, Research Associate I, Technical Operations & Supply Chain
Maria Chumpitaz, Research Associate I, Technical Operations & Supply Chain
Brenda Clemente, Associate Director, Head of Formulation and Process Development
Brenda Clemente, Associate Director, Head of Formulation and Process Development
Diana Correa, Research Associate II, Analytical Development
Diana Correa, Research Associate II, Analytical Development
Connie Crowley , Executive Director, Senior Clinical Scientist
Connie Crowley , Executive Director, Senior Clinical Scientist
Alex Daily, Purchasing Manager
Alex Daily, Purchasing Manager
ThanhChau Dam, Senior Research Associate II, In Vivo Pharmacology
ThanhChau Dam, Senior Research Associate II, In Vivo Pharmacology
Michael Davis  , Research Associate I, Formulation Development
Michael Davis , Research Associate I, Formulation Development
Michael Delbuono, Senior Research Associate I, Analytical Development
Michael Delbuono, Senior Research Associate I, Analytical Development
Yisong Deng, Scientist II, Analytical Development
Yisong Deng, Scientist II, Analytical Development
Nadja El-Mecharrafie, Senior Research Associate I, Frontier Science
Nadja El-Mecharrafie, Senior Research Associate I, Frontier Science
Michael Endow , Research Associate I, Drug Substance
Michael Endow , Research Associate I, Drug Substance
Peter Farrell, Chairman of the Board
Peter Farrell, Chairman of the BoardBio
Adam Finochio, Research Associate I, Formulation Development
Adam Finochio, Research Associate I, Formulation Development
Cindy Fisher , Executive Director, Regulatory Affairs
Cindy Fisher , Executive Director, Regulatory Affairs
Daniel Garcia , Scientist I, Translational Biology
Daniel Garcia , Scientist I, Translational Biology
David Geller, Vice President, Clinical Development for Pulmonary and Rare Diseases
David Geller, Vice President, Clinical Development for Pulmonary and Rare DiseasesBio
Nicole Gillies , Executive Assistant
Nicole Gillies , Executive Assistant
Brett Hill , Scientist I, Technology Innovation & Development
Brett Hill , Scientist I, Technology Innovation & Development
Jose Gonzales, Senior Research Associate II & Vivarium Supervisor
Jose Gonzales, Senior Research Associate II & Vivarium Supervisor
Jennifer Goodfellow, Executive Director, Strategic Sourcing Head
Jennifer Goodfellow, Executive Director, Strategic Sourcing Head
Yurong Guo, Director, Analytical Development
Yurong Guo, Director, Analytical Development
Kyle Gutsadt, Senior Analyst, Investor Relations & Public Relations
Kyle Gutsadt, Senior Analyst, Investor Relations & Public Relations
Paula Hartman, Project Manager
Paula Hartman, Project Manager
Steve Hughes, Strategic Clinical Advisor
Steve Hughes, Strategic Clinical AdvisorBio
Michael Hodges, R&D & Medical Consultant
Michael Hodges, R&D & Medical ConsultantBio
Dr. Ed Holmes, Director of the Board
Dr. Ed Holmes, Director of the BoardBio
Hyojung Hong, Research Associate II-Technology Innovation and Development, Platform Formulation Development
Hyojung Hong, Research Associate II-Technology Innovation and Development, Platform Formulation Development
Hannah Huynh, Laboratory Coordinator
Hannah Huynh, Laboratory Coordinator
Hongfan Jin , Director, Bioanalytical
Hongfan Jin , Director, Bioanalytical
Michelle Kim, Research Associate II, Analytical Development
Michelle Kim, Research Associate II, Analytical Development
Mukunda Krishna, Associate Director, External Mfg, Technical Ops & Supply Chain
Mukunda Krishna, Associate Director, External Mfg, Technical Ops & Supply Chain
Kristen Kuakini, Senior Research associate I, Technical Ops & Supply Chain
Kristen Kuakini, Senior Research associate I, Technical Ops & Supply Chain
Greg Kubczak, Senior Director Manufacturing & CMC Supply Operations, Technical Ops & Supply Chain
Greg Kubczak, Senior Director Manufacturing & CMC Supply Operations, Technical Ops & Supply Chain
KC Kummerfeld, SVP Finance and Corporate Controller
KC Kummerfeld, SVP Finance and Corporate ControllerBio
Lance Kurata, Chief Legal Officer
Lance Kurata, Chief Legal OfficerBio
Annalee Ledesma, Associate Director, Program Management
Annalee Ledesma, Associate Director, Program Management
Angel Leu, Senior Research Associate II, Frontier Science
Angel Leu, Senior Research Associate II, Frontier Science
Pattraranee (Patty) Limphong, Director, Bioanalytical
Pattraranee (Patty) Limphong, Director, Bioanalytical
Kelly Lindert, Chief Development Officer, Vaccines
Kelly Lindert, Chief Development Officer, VaccinesBio
Rob Lopez, Facilities & Logistics Specialist
Rob Lopez, Facilities & Logistics Specialist
Tim Luger, Senior Research Associate I, Drug Substance
Tim Luger, Senior Research Associate I, Drug Substance
Brian Luk , Senior Scientist, Formulation Development
Brian Luk , Senior Scientist, Formulation Development
Quang Ly , Process Engineer II, Drug Product
Quang Ly , Process Engineer II, Drug Product
Dr. Jing L. Marantz, M.D., Ph.D, MBA, Director of the Board
Dr. Jing L. Marantz, M.D., Ph.D, MBA, Director of the BoardBio
Dr. Magda Marquet, Director of the Board
Dr. Magda Marquet, Director of the BoardBio
Rohit Mahajan , Executive Director, Head of Analytical Development
Rohit Mahajan , Executive Director, Head of Analytical Development
John McHale , Research Associate I, Technology Innovation & Development
John McHale , Research Associate I, Technology Innovation & Development
Alana Montoya, Senior Research Associate II, Drug Substance
Alana Montoya, Senior Research Associate II, Drug Substance
Rajesh Mukthavaram, Senior Manager, Formulation Development
Rajesh Mukthavaram, Senior Manager, Formulation Development
Deirdre Murphy , Research Associate II, Analytical Development
Deirdre Murphy , Research Associate II, Analytical Development
Kat Murphy, Senior Director, Clinical Operations
Kat Murphy, Senior Director, Clinical Operations
Andy Ngo, Research Associate II, RNA Production
Andy Ngo, Research Associate II, RNA Production
Jimmy Nguyen , Research Associate II, Technology Innovation and Development, Pharmaceutics Team
Jimmy Nguyen , Research Associate II, Technology Innovation and Development, Pharmaceutics Team
Raju Nilkanthache , Associate Director, Stability
Raju Nilkanthache , Associate Director, Stability
Cristine Ohlson, Contracts Administrator/Paralegal
Cristine Ohlson, Contracts Administrator/Paralegal
Ariel Olesco , Research Associate I, Technology Innovation and Development, Platform Formulation Development
Ariel Olesco , Research Associate I, Technology Innovation and Development, Platform Formulation Development
Mario Ornelas, Senior Manager, Quality
Mario Ornelas, Senior Manager, Quality
Jinho Park, Scientist II, Technology Innovation and Development, Pharmaceutics Team
Jinho Park, Scientist II, Technology Innovation and Development, Pharmaceutics Team
Suezanne Parker, Senior Vice President, Translational Biology
Suezanne Parker, Senior Vice President, Translational BiologyBio
Deep Patel, Senior Manager, MSAT
Deep Patel, Senior Manager, MSAT
Joseph E. Payne, President & CEO, Director of the Board
Joseph E. Payne, President & CEO, Director of the BoardBio
Yihua Pei, Scientist II, Formulation Development
Yihua Pei, Scientist II, Formulation Development
Gregory Peters , Clinical Trial Supply Chain
Gregory Peters , Clinical Trial Supply Chain
Jennifer Potter , Executive Assistant
Jennifer Potter , Executive Assistant
Linda Quirino, Senior Research Associate, Translational Biology
Linda Quirino, Senior Research Associate, Translational Biology
Huda Rabi, Research Associate II, Formulation Development
Huda Rabi, Research Associate II, Formulation Development
Kumar Rajappan, Senior Principal Scientist, Chemistry
Kumar Rajappan, Senior Principal Scientist, Chemistry
Tyler Raymer, Senior Manager, Facilities
Tyler Raymer, Senior Manager, Facilities
Paloma Martinez Redondo, Senior Scientist, Translational Biology
Paloma Martinez Redondo, Senior Scientist, Translational Biology
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Pamela Resch, Executive Director, Quality and Regulatory Affairs
Joseph Roberts, Assistant Controller
Joseph Roberts, Assistant Controller
Fred del Rosario, Senior Director, Information Technology
Fred del Rosario, Senior Director, Information Technology
Qian Ruan, VP, Technical Operations & Manufacturing
Qian Ruan, VP, Technical Operations & ManufacturingBio
David Russo , Research Associate II, Analytical Development
David Russo , Research Associate II, Analytical Development
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Cristiano Sacchetti, Senior Scientist, Bioanalytical
Hazel Santos, Accounts Payable Specialist
Hazel Santos, Accounts Payable Specialist
Andrew Sassine, Chief Financial Officer
Andrew Sassine, Chief Financial Officer
Noa Scott, Human Resources Manager
Noa Scott, Human Resources Manager
Kyle Scurlock, SEC Reporting Manager
Kyle Scurlock, SEC Reporting Manager
Rose Sekulovich, Vice President of Bioanalytical, Translational Biology
Rose Sekulovich, Vice President of Bioanalytical, Translational Biology
Henry Shafron, Research Associate II, Analytical Development
Henry Shafron, Research Associate II, Analytical Development
Anna Shishina , Scientist II, Analytical Development
Anna Shishina , Scientist II, Analytical Development
Donna Singh , Senior Document Specialist
Donna Singh , Senior Document Specialist
Ajit Simh, Senior Vice President, Head of Global Quality
Ajit Simh, Senior Vice President, Head of Global QualityBio
Matt Sharma, Senior Clinical Trial Manager
Matt Sharma, Senior Clinical Trial Manager
Sourabh Shukla , Senior Scientist, Bioanalytical
Sourabh Shukla , Senior Scientist, Bioanalytical
Kevin Skol, Senior Vice President, Business Development & Alliance Management
Kevin Skol, Senior Vice President, Business Development & Alliance ManagementBio
Claine Snow, Sr. IP & Transactions Counsel
Claine Snow, Sr. IP & Transactions Counsel
Benchawanna SoontornniyomkijI, Senior Research Associate I, Translational Biology
Benchawanna SoontornniyomkijI, Senior Research Associate I, Translational Biology
Tyler Spencer, Finance Manager
Tyler Spencer, Finance Manager
Brian Sullivan , Principal Scientist, Vaccines & Immunology
Brian Sullivan , Principal Scientist, Vaccines & Immunology
Sean Sullivan, Vice President, Head of Technology Innovation
Sean Sullivan, Vice President, Head of Technology Innovation
Kiyoshi Tachikawa, Executive Director, Frontier Science
Kiyoshi Tachikawa, Executive Director, Frontier Science
Viraj Talpade , Associate Director, IT Infrastructure & Security
Viraj Talpade , Associate Director, IT Infrastructure & Security
Wendy Taylor, Vice President, Operations
Wendy Taylor, Vice President, Operations
Phuong-Danh Tran, Research Associate II, Technology Innovation and Development, Pharmaceutics Team
Phuong-Danh Tran, Research Associate II, Technology Innovation and Development, Pharmaceutics Team
Ramon Diaz Trelles, Principal Scientist, Drug Discovery
Ramon Diaz Trelles, Principal Scientist, Drug Discovery
Dushyant Varshney, Executive Vice President & Chief Technology Officer
Dushyant Varshney, Executive Vice President & Chief Technology OfficerBio
Aishwarya Vasudevan , Research Associate II, Formulation Development
Aishwarya Vasudevan , Research Associate II, Formulation Development
Simone Ward, Senior IP Counsel, Life Science
Simone Ward, Senior IP Counsel, Life Science
Kaitlin Werle , Laboratory Manager Translational Biology
Kaitlin Werle , Laboratory Manager Translational Biology
Nancy Wilk , Benefits & Payroll Manager
Nancy Wilk , Benefits & Payroll Manager
Hector Xiao , Manager, Analytical Operations & Supply
Hector Xiao , Manager, Analytical Operations & Supply
Yuval Yarkoni , Senior Manager, Operational Technical Lead
Yuval Yarkoni , Senior Manager, Operational Technical Lead
Rodrigo Yelin, Director, Program Management
Rodrigo Yelin, Director, Program Management
Ye Zhang , Senior Vice President, Head of Regulatory Affairs
Ye Zhang , Senior Vice President, Head of Regulatory AffairsBio
Zheng Zheng , Scientist II, Analytical Development
Zheng Zheng , Scientist II, Analytical Development

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA chemistry and delivery technologies.

 

News & Events
March 4, 2013
Arcturus Therapeutics Begins Operations in Janssen Labs
READ MORE
May 8, 2013
Arcturus Therapeutics Announces New Appointments to its Board of Directors and Scientific Advisory Board
READ MORE
November 8, 2021
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
READ MORE
November 18, 2021
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
November 22, 2021
Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
READ MORE
December 13, 2021
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
READ MORE
December 16, 2021
Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical Trials
READ MORE
January 24, 2022
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants
READ MORE
January 25, 2022
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial
READ MORE
February 8, 2022
Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
READ MORE
February 16, 2022
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
READ MORE
February 28, 2022
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
READ MORE
March 25, 2022
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
READ MORE
April 20, 2022
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
READ MORE
April 27, 2022
Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022
READ MORE
May 5, 2022
Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster Trial
READ MORE
May 9, 2022
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
READ MORE
August 1, 2022
Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022
READ MORE
August 9, 2022
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
READ MORE
August 18, 2022
Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine
READ MORE
August 31, 2022
Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response
READ MORE
September 1, 2022
Arcturus Therapeutics to Attend the Following Investor Conferences
READ MORE
X